1Giannoukakis N,Rudert WA,Robbins PD et al.Targeting autoimmune diabetes with gene therapy.Diabetes,1999,48(11):2107
2Sui G,Soohoo C,Affarel B et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America,2002,99(8):5515
3Alberto P,Douglas B,David G et al.Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripherallymphoid organs.J Clin Invest,2001,107(5):555
4Pileggi A,Molano RD,Berney T et al.Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation.Diabetes,2001,50(9):1983
5Burkhardt BR,Parker MJ,Zhang YC et al.Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice.FEBS Lett,2005,579(25):5759
6Iynedjian PB,Jotterand D,Nouspikel T et al.Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system.J Biol Chem,1989,264(36):21824
7Lipes MA,Davalli AM,Cooper EM et al.Genetic engineering of insulin expression in nonislet cells:implications for b-cell replacement therapy for insulin-dependent diabetes mellitus.Acta Diabetol,1997,34(1):2
8Wagers AJ,Christensen JL,Weissman IL et al.Cell fate determination from stem cells.Gene Therapy,2002,9(10):606
9Efrat S,Fusco-DeMane D,Lemberg H et al.Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracyclineregulated oncogene.Proc Natl Acad Sci USA,1995,92(8):3576
10Zalzman M,Anker-Kitai L,Efrat S et al.Differentiation of human liver-derived,insulin-producing cells toward the beta-cell phenotype.Diabetes,2005,54(9):2568
